Alopecia Areata
January 2024
in “
Elsevier eBooks
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Research cited in this study 78
- Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial
- An Overview of JAK/STAT Pathways and JAK Inhibition in Alopecia Areata
- The Efficacy and Safety of JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis of Prospective Studies
- Platelet-Rich Plasma in Alopecia Areata: A Steroid-Free Treatment Modality - A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management
- A Phase 2a Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of the Oral Janus Kinase Inhibitors Ritlecitinib and Brepocitinib in Alopecia Areata: 24-Week Results
- Platelet-Rich Plasma in the Treatment of Alopecia Areata: A Review
- Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata
- Efficacy of Antihistamines in Combination with Topical Corticosteroid and Superficial Cryotherapy for Treatment of Alopecia Areata: A Retrospective Cohort Study
- New and Emerging Therapies for Alopecia Areata
- Apremilast for Extensive and Treatment-Resistant Alopecia Areata: A Retrospective Analysis of Five Patients
- A Hair-Raising History of Alopecia Areata
- JAK Inhibition in the Treatment of Alopecia Areata: A Promising New Dawn?
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Italian Guidelines in Diagnosis and Treatment of Alopecia Areata
- Frontiers in Alopecia Areata Pathobiology Research
- Efficacy of the Phosphodiesterase-4 Inhibitor, Apremilast, in a Patient with Severe Alopecia Areata
- Apremilast Is Efficacious in Refractory Alopecia Areata
- Cyclosporine for Moderate-to-Severe Alopecia Areata: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety
- Identification of Blood MicroRNA Alterations in Patients With Severe Active Alopecia Areata
- Scalp Bacterial Shift in Alopecia Areata
- Alopecia Diffusa While Using Interleukin-17 Inhibitors Against Psoriasis Vulgaris
- Alopecia Areata: A Long-Term Follow-Up Study of 104 Patients
- JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis
- Tofacitinib Therapy for Children with Severe Alopecia Areata
- Alopecia Areata: A Multifactorial Autoimmune Condition
- A Randomized Placebo-Controlled Single-Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects with Moderate-to-Severe Alopecia Areata
- Treatment of Alopecia Areata: An Australian Expert Consensus Statement
- Response to Ustekinumab in Three Pediatric Patients with Alopecia Areata
- Tofacitinib for the Treatment of Alopecia Areata in Preadolescent Children
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis
- Alopecia Areata: A Review of Disease Pathogenesis
- iNKT Cells Ameliorate Human Autoimmunity: Lessons from Alopecia Areata
- Trichoscopy of Alopecia Areata: An Update
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Nail Changes in Alopecia Areata: An Update and Review
- Novel Therapies for Alopecia Areata: The Era of Rational Drug Development
- Alopecia Areata: Treatment Options and Efficacy
- Alopecia Areata: Overview and Insights from January 2018
- Identification of Differentially Expressed miRNAs in Alopecia Areata That Target Immune-Regulatory Pathways
- Tofacitinib for the Treatment of Alopecia Areata and Variants in Adolescents
- Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients
- Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata
- Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata
- Genomewide Analysis of Copy Number Variants in Alopecia Areata in a Central European Cohort Reveals Association with MCHR2
- ULBP3: A Marker for Alopecia Areata Incognita
- Pulse Corticosteroid Therapy With Oral Dexamethasone for the Treatment of Adult Alopecia Totalis and Universalis
- A Systematic Review of Pulse Steroid Therapy for Alopecia Areata
- Extensive Alopecia Areata Is Reversed by IL-12/IL-23p40 Cytokine Antagonism
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Epidemiology and Burden of Alopecia Areata: A Systematic Review
- Imbalance of T-Helper 17 and Regulatory T Cells in Patients with Alopecia Areata
- Plasmacytoid Dendritic Cells in Alopecia Areata: Missing Link?
- The PDE4 Inhibitor, Apremilast, Suppresses Experimentally Induced Alopecia Areata in Human Skin In Vivo
- Inhibiting Janus Kinases to Treat Alopecia Areata
- Diagnostic Usefulness of a Peribulbar Eosinophilic Infiltrate in Alopecia Areata
- Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition
- Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children
- Autoimmune Disease Induction in a Healthy Human Organ: A Humanized Mouse Model of Alopecia Areata
- Histopathology of Scarring and Nonscarring Hair Loss
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- British Association of Dermatologists’ Guidelines for the Management of Alopecia Areata 2012
- Alopecia Areata: An Autoimmune Disease Causing Hair Loss
- Diffuse Alopecia Areata Is Associated With Intense Inflammatory Infiltration and CD8+ T Cells in Hair Loss Regions and an Increase in Serum IgE Level
- Abnormal Epigenetic Modifications in Peripheral Blood Mononuclear Cells from Patients with Alopecia Areata
- Histologic Features of Alopecia Areata Other Than Peribulbar Lymphocytic Infiltrates
- Utility of Dermoscopy in Alopecia Areata
- Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity
- Experimental Evaluation of Ebastine, a Second-Generation Antihistamine, as a Supportive Medication for Alopecia Areata
- Alopecia Areata Update
- Alefacept for Severe Alopecia Areata: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial
- The Functional Relevance of the Type 1 Cytokines IFN-γ and IL-2 in Alopecia Areata of C3H/HeJ Mice
- Placebo-Controlled Oral Pulse Prednisolone Therapy in Alopecia Areata
- Characterization of Hair Follicle Antigens Targeted by the Anti-Hair Follicle Immune Response
- Alopecia Areata in Aging C3H/HeJ Mice
Related research 1
Related Community Posts Join
6 / 1000+ resultscommunity Random bald spot suddenly appeared
A user noticed a sudden bald spot and others suggested it might be alopecia areata, often stress-induced, recommending seeing a dermatologist for steroid injections. Topical minoxidil was mentioned as a successful treatment by one user.
community Is this normal? (losing hair on side of head)
The user is concerned about potential alopecia areata. They are seeking advice on whether this condition is normal.
community What hair loss pattern is this?
The user noticed small circular hairless spots after a buzz cut and has been using finasteride, dutasteride, and oral minoxidil for hair loss. They are experiencing continuous shedding and thinning, and it is suggested they consult a dermatologist for a scalp examination and possible biopsy to determine if it's alopecia areata or androgenetic alopecia.
community 35M with alopecia areata - Treatments failing, next steps?
A 35-year-old with alopecia areata has tried finasteride, topical and oral minoxidil, and dutasteride without success in stopping hair loss. The dermatologist suggests JAK inhibitors, but they are too costly, leading to uncertainty about the cause of hair loss.
community Diet changes w Alopecia areata.
The conversation discusses alopecia areata and whether diet changes can resolve it. One user mentions that their condition fluctuates without dietary changes, suggesting stress as a possible factor.
community 25M Exploring Causes of Hair Loss: TE, Alopecia, or AGA?
The user is experiencing hair loss with possible causes including chronic telogen effluvium, diffuse alopecia areata, and androgenic alopecia. They have tried treatments like Nizoral shampoo, minoxidil, and finasteride, and are considering a biopsy for further clarity.